• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,417.92
  • 0.52 %
  • $197.29
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Novo Integrated Sciences, Inc. (NVOS) Stock Price, News & Analysis

Novo Integrated Sciences, Inc. (NVOS) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.05

$0.01

(35.73%)

Day's range
$0.04
Day's range
$0.05
50-day range
$0.027
Day's range
$0.3486
  • Country: US
  • ISIN: US67011T3005
52 wk range
$0.03
Day's range
$1.62
  • CEO: Mr. Robert Mattacchione
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -5.37
  • Piotroski Score 3.00
  • Grade N/A
  • Symbol (NVOS)
  • Company Novo Integrated Sciences, Inc.
  • Price $0.05
  • Changes Percentage (35.73%)
  • Change $0.01
  • Day Low $0.04
  • Day High $0.05
  • Year High $1.62

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 12/12/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.21
  • Trailing P/E Ratio -4.11
  • Forward P/E Ratio -4.11
  • P/E Growth -4.11
  • Net Income $-13,214,552

Income Statement

Quarterly

Annual

Latest News of NVOS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Novo Integrated Sciences, Inc. Frequently Asked Questions

  • What is the Novo Integrated Sciences, Inc. stock price today?

    Today's price of Novo Integrated Sciences, Inc. is $0.05 — it has increased by +35.73% in the past 24 hours. Watch Novo Integrated Sciences, Inc. stock price performance more closely on the chart.

  • Does Novo Integrated Sciences, Inc. release reports?

    Yes, you can track Novo Integrated Sciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Novo Integrated Sciences, Inc. stock forecast?

    Watch the Novo Integrated Sciences, Inc. chart and read a more detailed Novo Integrated Sciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Novo Integrated Sciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Novo Integrated Sciences, Inc. stock ticker.

  • How to buy Novo Integrated Sciences, Inc. stocks?

    Like other stocks, NVOS shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Novo Integrated Sciences, Inc.'s EBITDA?

    Novo Integrated Sciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Novo Integrated Sciences, Inc.’s financial statements.

  • What is the Novo Integrated Sciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -1.0511081792, which equates to approximately -105.11%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Novo Integrated Sciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Novo Integrated Sciences, Inc.'s financials relevant news, and technical analysis. Novo Integrated Sciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Novo Integrated Sciences, Inc. stock currently indicates a “sell” signal. For more insights, review Novo Integrated Sciences, Inc.’s technical analysis.

  • A revenue figure for Novo Integrated Sciences, Inc. for its last quarter?

    Novo Integrated Sciences, Inc. published it's last quarterly revenues at $3.15 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.